Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2026-06-15 @ 8:41 PM
Study NCT ID:
NCT01208103
Status:
COMPLETED
Last Update Posted:
2020-09-03
First Post:
2010-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Ampulla of Vater Adenocarcinoma | View |
| None | Small Intestinal Adenocarcinoma | View |
| None | Stage III Ampulla of Vater Cancer AJCC v8 | View |
| None | Stage III Small Intestinal Adenocarcinoma AJCC v8 | View |
| None | Stage IIIA Ampulla of Vater Cancer AJCC v8 | View |
| None | Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 | View |
| None | Stage IIIB Ampulla of Vater Cancer AJCC v8 | View |
| None | Stage IIIB Small Intestinal Adenocarcinoma AJCC v8 | View |
| None | Stage IV Ampulla of Vater Cancer AJCC v8 | View |
| None | Stage IV Small Intestinal Adenocarcinoma AJCC v8 | View |
Keywords: